Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01263574
Recruitment Status : Withdrawn (No participants. IND denied by FDA.)
First Posted : December 20, 2010
Last Update Posted : June 22, 2017
Information provided by (Responsible Party):
Tom Jaksic, Boston Children’s Hospital

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2012
  Estimated Study Completion Date : September 2012